#AIEye #Podcast 621: #Stocks discussed: (OTCPINK: $GTCHD) (NYSE: $JNPR) #artificialintelligence

 

 

#AIEye #Podcast 621: #Stocks discussed: (OTCPINK: $GTCHD) (NYSE: $JNPR) #artificialintelligence

 

GBT Training Avant! AI Derivative Hippocrates, and Juniper Networks Extends AI-Driven Support to Junos Portfolio

 

Global #AI in #Manufacturing Market to Reach $13.96B in 2028

 

Point Roberts WA, Vancouver BC – November 3, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence  –  featuring technology company GBT Technologies Inc. (OTCPINK:GTCHD).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/110321-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/11031GTCHD-JNPR.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCHD) (NYSE:JNPR)

 

GBT Technologies Inc. (OTC PINK:GTCHD) has announced that it is training a derivative system of its Avant! AI called Hippocrates, which aims to “create an intelligent health advisory system.” GBT’s CTO, Danny Rittman, explained:

 

“We are in the process of training Hippocrates with accredited medical textbooks that are taught in medical schools. Additionally, we will be connecting the Hippocrates system with governmental health resources, among them are CDC, and the NCBI. The aim is to provide our AI agent with a vast amount of health-related materials to enable first line health advice and tips. The system will have cognitive capabilities to learn from its own experience and ultimately reason and predict accordingly. The health advisor agent will interact with users through a website interface and mobile application. GBT believes that artificial intelligence solutions are going to become more prominent in our new era, and plans to create a set of health-related solutions via hardware, [the] qTerm device, and supporting AI computer programs. Naturally, we plan to integrate the Hippocrates system with our qTerm device sometime during 2022. These systems aim to assist individuals and health professionals to provide better and faster healthcare anywhere around the world. The training of our Hippocrates system is the first step of building an intelligent health advisory agent that learns from vast data resources and its own experience; ultimately, becoming more knowledgeable over time, as a human does.”

 

Juniper Networks, Inc. (NYSE:JNPR) has announced that it is extending its AI-driven support to its entire Junos portfolio. Derrell James, EVP of Juniper Global Services, said:

 

"The use of data and automation are redefining how customer experience is delivered. Juniper Support Insights represents a major step forward in how we’re transforming services with a focus on personalized, proactive and predictive experience leveraging AI and cloud. With a new level of end-to-end visibility and actionable intelligence, Juniper is making it easier for service providers, enterprises and partners to optimize the operation of their networks."

 

Global AI in Manufacturing Market to Reach $13.96B in 2028

 

A report published by Meticulous Research finds that the global AI in Manufacturing market will grow to $13.96 billion USD in the forecast period 2021-2028, registering a compound annual growth rate (CAGR) of 38.6 percent. An excerpt from the report’s description reads:

 

The rising popularity of artificial intelligence in manufacturing industries for optimizing logistics & supply chains, reducing costs and downtime in production lines, the advent of Industrial 4.0, increasing volume of large complex data, and the rising adoption of industrial IoT are the key factors driving the growth of the AI in manufacturing market. Additionally, the growing scale of manufacturing operations in emerging economies, rising acceptance of modern manufacturing techniques, and increasing deployment of automation technologies are expected to offer significant growth opportunities for the growth of the AI in manufacturing market.

 

However, privacy and data protection concerns are a major challenge expected to hinder the growth of the AI in the manufacturing market.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCHD is a paid featured AI stock on investorideas Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCHD) Started its AI System Training with Health-Related Big Data, Aiming to Create an Intelligent Health Advisor Agent, Named Hippocrates; #Artificialintelligence

Breaking #AI #Health #Stock News: GBT (OTCPK: $GTCHD) Started its AI System Training with Health-Related Big Data, Aiming to Create an Intelligent Health Advisor Agent, Named Hippocrates; #Artificialintelligence

 

The Hippocrates system - an Avant! derivative, will be trained with vast amounts of health-related information, using accredited medical textbooks and health-related data resources

 

San Diego, CA, November 2, 2021 – (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCHD) ("GBT”, or the “Company”), is now training its Hippocrates system, an Avant! AI derivative system, with health-related big data, aiming to create an intelligent health advisory system. The company started “teaching” Avant! medical data using accredited medical textbooks used in medical schools. The AI system will learn the information to provide first line, health related advice and tips. Additionally, the company plans to connect with governmental and professional accredited data resources, among them are the CDC (Center of Dieses Control and Prevention - Centers for Disease Control and Prevention (cdc.gov)) and the NCBI (National Center for Biotechnology Information - National Center for Biotechnology Information (nih.gov)), as additional references.

 

Read this news, featuring GTCHD in full at https://www.investorideas.com/CO/GOPH/news/2021/11021Hippocrates.asp

 

The AI system is targeted to potentially understand a user’s question, analyze the information conclude and advise. Hippocrates will be equipped with an initial vast amount of health-related data and cognitively grow its knowledge over time, learning from its own experiences, the same way a human does. The system’s big data system incorporates components of data mining, statistics, and predictive analysis, extracting knowledge and insights from huge amounts of information. The system’s methodologies and algorithms provide a high precision of big data analytics enabling reasoning and learning capabilities. Hippocrates will be available through both web and mobile applications.

 

The system’s main advantage potentially, is the capability to combine flexibility and agility with rigorous data analysis; scientifically, extracting value from huge data sets. It applies data science methods to address the needs of a new era of intelligent healthcare, aiming to benefit patients and healthcare professionals, addressing the challenges of providing rapid healthcare services anywhere around the world. The company is evaluating monetizing the system via clinics/hospitals licensing or individual’s fees.

 

“The Hippocrates system is a derivative-system of our Avant! AI and is now under massive data training to become an efficient data-driven information health advisory agent. We are in the process of training Hippocrates with accredited medical textbooks that are taught in medical schools. Additionally. we will be connecting the Hippocrates system with governmental health resources, among them are CDC, and the NCBI. The aim is to provide our AI agent with vast amount of health-related materials to enable a first line health advice and tips. The system will have cognitive capabilities to learn from its own experience and ultimately reason and predict accordingly. The health advisor agent will interact with users through a website interface and mobile application. GBT believes that artificial intelligence solutions are going to become more prominent in our new era, and plans to create a set of health-related solutions via hardware, qTerm device, and supporting AI computer programs. Naturally, we plan to integrate the Hippocrates system with our qTerm device sometime during 2022. These systems aim to assist individuals and health professional to provide better and faster healthcare anywhere around the world. The training of our Hippocrates system is the first step of building an intelligent health advisory agent that learns from vast data resources and its own experience; ultimately, becoming more knowledgeable over time, as a human does,” said Danny Rittman the Company’s CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, and fully developed, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCHD) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCHD) is a featured tech stock on

Investorideas.com

 

More info on GTCHD at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCHD

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCHD is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

#AIEye #Podcast 620: #Stocks discussed: (Nasdaq: $KLAC) (Nasdaq: $LTRN) #artificialintelligence

 

 

#AIEye #Podcast 620: #Stocks discussed: (Nasdaq: $KLAC) (Nasdaq: $LTRN) #artificialintelligence

 

KLA Corporation Opening AI Advanced Computing Lab in India, and Lantern Pharma’s RADR AI Platform Exceeds 10.4 Billion Datapoints

 

Conversational #AI Market to Reach $18.4B by 2026

 

Point Roberts WA, Vancouver BC – November 1, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/110121-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/11011KLAC-LTRN.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NasdaqGS:KLAC) (NasdaqCM:LTRN)

 

KLA Corporation (NasdaqGS:KLAC) has announced the opening of two facilities in Chennai, India, including the Artificial Intelligence-Advanced Computing Lab (AI-ACL) – operated in partnership with the Indian Institute of Technology (IIT) Madras – which “will serve as a center of excellence for AI-focused research and development.” Ahmad Khan, president, semiconductor process control at KLA, said:

 

"KLA is at the forefront of using AI technology in our process control systems to identify and isolate critical issues in chip manufacturing. To expand the reach of AI in our products and develop the next generation of AI innovations, we created our new AI-ACL research facility. Our researchers and engineers at AI-ACL join the AI experts at our AI Modeling and Center of Excellence in Michigan to form a global team committed to advancing the boundaries of AI, software, image processing and physics modeling."

 

Lantern Pharma Inc. (NasdaqCM:LTRN) has announced that its proprietary A.I. platform RADR – which is used to “transform the cost, pace, and timeline of oncology drug discovery and development” – has exceeded 10.4 billion datapoints. The company’s President and CEO, Panna Sharma, explained:

 

"Our team has been well ahead of schedule in the growth of our platform, and RADR^® has now surpassed 10.4 billion data points covering more cancer sub-types, which further advances our goal of building the most complete and powerful A.I. platform for precision oncology drug development. Additionally, the new data will drive insights and potential drug-candidate innovations faster and into areas of cancer that have remained untouched or intractable."

 

 

Conversational AI Market to Reach $18.4B by 2026

 

A report published by Markets and Markets finds that the global Conversational AI market is projected to grow from $6.8 billion in 2021 to $18.4 billion by 2026, registering a compound annual growth rate (CAGR) of 21.8 percent in the forecast period. An excerpt from the report’s description outlines factors influencing the market’s growth:

 

The major factors driving the growth of the conversational AI market are the increasing demand for AI-powered customer support services, omnichannel deployment, and reduced chatbot development costs. Furthermore, the rising demand for AI-based chatbots to stay connected and informed during COVID-19 and increasing focus on customer engagement are the major factors adding value to the conversational AI offerings, which is expected to provide opportunities for enterprises operating in various verticals in the conversational AI market. The lack of accuracy in chatbots and virtual assistants and maintaining business continuity during the COVID-19 pandemic are the major challenges in the conversational AI market. Moreover, the lack of awareness about conversational AI solutions and the inability to identify customer intent and respond effectively act as the key restraining factors in the market.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories